atropine has been researched along with sildenafil citrate in 8 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (sildenafil citrate) | Trials (sildenafil citrate) | Recent Studies (post-2010) (sildenafil citrate) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 5,862 | 956 | 2,319 |
| Protein | Taxonomy | atropine (IC50) | sildenafil citrate (IC50) |
|---|---|---|---|
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.0036 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Baniel, J; Engelstein, D; Israilov, S; Livne, PM; Niv, E; Segenreich, E; Shmueli, J | 1 |
| Daabees, TT; El-Metwally, MA; Senbel, AM; Sharabi, FM | 1 |
| Brink, CB; Clapton, JD; Eagar, BE; Harvey, BH | 1 |
| Brink, CB; Harvey, BH; Liebenberg, N; Wegener, G | 1 |
| Brand, L; Brink, CB; Harvey, BH; Liebenberg, N | 1 |
| Borges, MN; Cardoso, VN; Cordeiro, MN; De Lima, ME; Diniz, SO; Leite, R; Nunes, KP; Richardson, M; Tostes, R; Webb, RC | 1 |
| Baba, T; Iijima, S; Ohishi, A; Ueno, D | 1 |
1 review(s) available for atropine and sildenafil citrate
| Article | Year |
|---|---|
Hypertrophic pyloric stenosis following persistent pulmonary hypertension of the newborn: a case report and literature review.
Topics: Antihypertensive Agents; Atropine; Bosentan; Bronchodilator Agents; Female; High-Frequency Ventilation; Humans; Infant, Newborn; Meconium Aspiration Syndrome; Muscarinic Antagonists; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Persistent Fetal Circulation Syndrome; Pyloric Stenosis, Hypertrophic; Sildenafil Citrate; Vasodilator Agents | 2018 |
7 other study(ies) available for atropine and sildenafil citrate
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Alprostadil; Atropine; Cardiovascular Diseases; Coitus; Contraindications; Drug Combinations; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Muscarinic Antagonists; Papaverine; Penis; Phentolamine; Piperazines; Purines; Retreatment; Sildenafil Citrate; Sulfones; Treatment Failure; Vasodilator Agents | 2002 |
Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Arginine; Atropine; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Electric Stimulation; Erectile Dysfunction; Guanethidine; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroarginine; Penile Erection; Penis; Phentolamine; Phenylephrine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Rabbits; Sildenafil Citrate; Sulfones; Yohimbine | 2004 |
Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies.
Topics: Animals; Antidepressive Agents; Atropine; Brain; Cell Line, Tumor; Fluoxetine; Humans; Male; Motor Activity; Muscarinic Antagonists; Neurons; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic; Receptors, Muscarinic; Signal Transduction; Sildenafil Citrate; Sulfones | 2008 |
Investigating the role of protein kinase-G in the antidepressant-like response of sildenafil in combination with muscarinic acetylcholine receptor antagonism.
Topics: Animals; Atropine; Behavior, Animal; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Depression; Disease Models, Animal; Drug Administration Routes; Drug Interactions; Drug Therapy, Combination; Freezing Reaction, Cataleptic; Male; Muscarinic Antagonists; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Statistics, Nonparametric; Sulfones; Swimming; Thionucleotides | 2010 |
Antidepressant-like properties of phosphodiesterase type 5 inhibitors and cholinergic dependency in a genetic rat model of depression.
Topics: Animals; Antidepressive Agents; Atropine; Behavior, Animal; Carbolines; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Rats; Sildenafil Citrate; Sulfones; Swimming; Tadalafil | 2010 |
Nitric oxide-induced vasorelaxation in response to PnTx2-6 toxin from Phoneutria nigriventer spider in rat cavernosal tissue.
Topics: Animals; Atropine; Calcium Channel Blockers; Calcium Channels, N-Type; Electric Stimulation; Male; Muscarinic Antagonists; Neuropeptides; Neurotoxins; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; omega-Conotoxin GVIA; Penis; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sildenafil Citrate; Spider Venoms; Sulfones; Technetium; Vasodilation | 2010 |